Skip to content

Using GPS trackers in dementia patients to improve quality of life

A longitudinal pilot study to investigate the use of GPS trackers in dementia patients who are at risk of wandering

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16242918
Enrollment
50
Registered
2022-05-09
Start date
2022-01-28
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of life of people diagnosed with dementia or memory impairment who are at risk of wandering or getting lost Mental and Behavioural Disorders Unspecified dementia

Interventions

This pilot study was developed as a collaboration between Southwest Yorkshire Partnership NHS Trust (SWYPT), Primary Care colleagues, South & West Yorkshire Police and the University of Huddersfield.

Sponsors

South West Yorkshire Partnership NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals must have a designated family member/close friend who will supervise the use of the device including being able to access and use the accompanying software. 2. Nominated friend must not be any member of paid care staff 3. Participants must live in an area served by South West Yorkshire Partnership NHS Trust memory services 4. Individuals must be either living in their own homes or in supported accommodation

Exclusion criteria

Exclusion criteria: 1. If an individual does not have a close family member identified at the outset, he/she will be excluded from the study 2. If participants move out of this area to a different locality before the end of six months duration of the study, they will cease to be part of the study 3. If individuals make a permanent move to a 24-hour residential care setting, they will cease to be part of the study

Design outcomes

Primary

MeasureTime frame
The number of participants who need admission to a 24-hour care facility such as a hospital, nursing home or residential home, measured using monthly check-in calls and/or post-trial supportive contact for 6 months

Secondary

MeasureTime frame
1. Number of times the GPS tracker has been used to retrieve the wearer, measured by liaising with individual dyads during monthly and post-trial supportive contacts for 6 months 2. Number of hospital admissions as a result of wandering, measured using the Revised Algase wandering scale at baseline (within 2 weeks before joining the study) and follow-up (end of 6 months in the study) 3. Number of times the police have needed to be contacted due to an incidence of wandering, measured using the Revised Algase wandering scale at baseline and follow-up, and review of police records 3. Quality of life of both wearer and carer, measured using the Zarit Burden interview questionnaire and Cornell-Brown Quality of life index at baseline (before joining the study) and follow-up (end of 6 months of joining the study) 4. Usability and acceptability of the product measured using the UoAlberta GPS useability questionnaire (Wearer & Carer) at follow up (end of 6 months of study)

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026